These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 24252606)

  • 41. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A; Pires J; Ellsworth P
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study.
    Park SJ; Park JM; Pai KS; Ha TS; Lee SD; Baek M;
    Pediatr Nephrol; 2014 Jul; 29(7):1195-200. PubMed ID: 24477979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating nocturnal enuresis in children in primary care.
    Bottomley G
    Practitioner; 2011 Jun; 255(1741):23-6, 2-3. PubMed ID: 21776914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?
    Schroeder MK; Juul KV; Mahler B; Nørgaard JP; Rittig S
    Eur J Pediatr; 2018 Mar; 177(3):389-394. PubMed ID: 29260376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Desmopressin for nocturnal enuresis in children.
    Glazener CM; Evans JH
    Cochrane Database Syst Rev; 2002; (3):CD002112. PubMed ID: 12137645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A randomized controlled clinical trial for treatment of children with primary nocturnal enuresis].
    Ma J; Zhang YW; Wu H; Jiang F; Jin XM
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):167-71. PubMed ID: 17504616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis.
    Vogt M; Lehnert T; Till H; Rolle U
    BJU Int; 2010 May; 105(10):1456-9. PubMed ID: 19764973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of isolated nocturnal enuresis: alarm or desmopressin?].
    Faraj G; Cochat P; Cavailles ML; Chevallier C
    Arch Pediatr; 1999 Mar; 6(3):271-4. PubMed ID: 10191892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
    Ezodin N; Sarouei M; Khademlo M; Milani SH; Yousefi S; Mohammadjafari H
    Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of primary nocturnal enuresis in children: a review.
    Brown ML; Pope AW; Brown EJ
    Child Care Health Dev; 2011 Mar; 37(2):153-60. PubMed ID: 20825424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial.
    Ghanavati PM; Khazaeli D; Amjadzadeh M
    Int Braz J Urol; 2021; 47(1):73-81. PubMed ID: 32840337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of desmopressin and enuresis alarm for nocturnal enuresis.
    Wille S
    Arch Dis Child; 1986 Jan; 61(1):30-3. PubMed ID: 3513716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
    Mello MF; Locali RF; Araujo RM; Reis JN; Saiovici S; Mello LF; Trigo Rocha FE
    J Pediatr Urol; 2023 Jun; 19(3):241-246. PubMed ID: 36717289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
    Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S
    BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.
    Juul KV; Van Herzeele C; De Bruyne P; Goble S; Walle JV; Nørgaard JP
    Eur J Pediatr; 2013 Sep; 172(9):1235-42. PubMed ID: 23677249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of the bell and pad alarm therapy for nocturnal enuresis.
    Gim CS; Lillystone D; Caldwell PH
    J Paediatr Child Health; 2009; 45(7-8):405-8. PubMed ID: 19712175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of traditional Chinese and Western medicine on nocturnal enuresis in children and indicators of treatment success: Randomized controlled trial.
    Ma Y; Liu X; Shen Y
    Pediatr Int; 2017 Nov; 59(11):1183-1188. PubMed ID: 28891253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.